SurModics (SRDX) Surges On License Deal With Roche and Genentech
Tweet Send to a Friend
Shares of SurModics Inc. (Nasdaq: SRDX) are rallying 24% in early trading today after the company entered a major License ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
